The total return for Humana Inc. (HUM) stock is +59.86% over the past 12 months vs. +22.13% for the S&P 500. So far it's up +43.22% this year. Includes price appreciation + reinvested dividends.
Humana Inc. (HUM) Compound Annual Growth Rates (CAGR) Summary
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +57.36% | (10.74%) | (2.82%) | +6.93% | +10.82% | +10.25% |
| Total Return CAGR | +59.86% | (9.67%) | (1.86%) | +7.83% | +11.82% | +11.00% |
| Revenue CAGR | +14.09% | +12.78% | +11.71% | +9.72% | +9.64% | +11.44% |
| Net Income CAGR | (33.94%) | (28.68%) | (21.21%) | +0.27% | (0.15%) | +7.29% |
| EPS CAGR | (1.40%) | (23.67%) | (17.27%) | +1.46% | +2.77% | +8.56% |
| Free Cash Flow CAGR | (46.60%) | (49.57%) | (17.19%) | +5.89% | (3.06%) | (0.33%) |
| Operating Cash Flow CAGR | (35.86%) | (44.81%) | (15.69%) | +4.02% | (1.41%) | +0.92% |
| Dividends CAGR | 0.00% | +3.97% | +7.21% | +11.90% | (4.18%) | (4.18%) |
CAGR Trends History
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
HUM Total Return CAGR Chart
Humana Inc. (HUM)
Annual Total Returns Comparison
| Year | Start Value | End Value | HUM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 1621.22 | 2321.91 | +43.22% | +7.07% | +36.15% |
| 2025 | 1583.78 | 1621.22 | +2.36% | +17.72% | (15.36%) |
| 2024 | 2826.13 | 1583.78 | (43.96%) | +24.89% | (68.85%) |
| 2023 | 3138.11 | 2826.13 | (9.94%) | +26.19% | (36.13%) |
| 2022 | 2823.29 | 3138.11 | +11.15% | (18.17%) | +29.32% |
| 2021 | 2480.95 | 2823.29 | +13.80% | +28.74% | (14.94%) |
| 2020 | 2201.49 | 2480.95 | +12.69% | +18.37% | (5.68%) |
| 2019 | 1707.37 | 2201.49 | +28.94% | +31.22% | (2.28%) |
| 2018 | 1468.42 | 1707.37 | +16.27% | (4.56%) | +20.83% |
| 2017 | 1197.75 | 1468.42 | +22.60% | +21.70% | +0.90% |
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin